The current Cialis patent is due to expire in November 2017. Post this, generic manufacturers will be licenced to supply generic Cialis by its active ingredient Tadalafil. Eli-Lilly, the manufacturer of Cialis has stated it will facilitate Cialis to be made available as an over-the-counter medication when the patent expires.